Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Sales | 1,913 | 2,475 | 3,357 | 2,056 | 1,098 |
| Cost of Goods | 1,924 | 2,340 | 2,994 | 1,998 | 1,432 |
| Gross Profit | -11 | 135 | 363 | 58 | -334 |
| Operating Expenses | 10,119 | 9,099 | 11,733 | 12,307 | 15,647 |
| Operating Income | -9,206 | -8,624 | -10,376 | -11,251 | -15,549 |
| Interest Expense | 1,847 | 1,188 | 659 | 669 | 669 |
| Other Income | 23 | 13 | 50 | 6 | -15 |
| Pre-tax Income | -11,030 | -9,799 | -10,985 | -11,914 | -16,233 |
| Net Income Continuous | -11,030 | -9,799 | -10,985 | -11,914 | -16,233 |
| Net Income | $-11,030 | $-9,799 | $-10,985 | $-11,914 | $-16,233 |
| EPS Basic Total Ops | -0.45 | -0.40 | -0.45 | -0.49 | -0.68 |
| EPS Basic Continuous Ops | -0.45 | -0.40 | -0.45 | -0.49 | -0.68 |
| EPS Diluted Total Ops | -0.45 | -0.40 | -0.45 | -0.49 | -0.68 |
| EPS Diluted Continuous Ops | -0.45 | -0.40 | -0.45 | -0.49 | -0.68 |
| EBITDA(a) | $-8,312 | $-7,715 | $-9,502 | $-10,418 | $-14,797 |